Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04496804 · ClinicalTrials.gov registry record · NA
Examining the Neural Effects of a Behavioral Intervention for Physical Activity in Multiple Sclerosis
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT04496804 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 24 participants.
The verdict
NCT04496804, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Multiple sclerosis \[MS\] is a prevalent neurological disease that is the leading cause of irreversible neurological disability among young women and the second leading cause of disability among young men in the United States. This disease results in the progressive loss of walking mobility and substantial worsening of cognition, symptoms, and quality of life over time. There is evidence that physical activity is beneficially associated with aerobic fitness and brain structure and function in persons with MS. Nevertheless, this population is strikingly sedentary and physically inactive. This highlights a vital opportunity to improve aerobic fitness and brain health by developing behavioral interventions that increase physical activity. To that end, this project is a Phase-II randomized control trial for examining the efficacy of a behavioral intervention that is based on social-cognitive theory and delivered through the Internet for increasing physical activity and, secondarily, improving aerobic fitness and brain structure and function in persons with MS.
Interventions
- BEHAVIORAL Behavioral Intervention for Physical Activity in MS (BIPAMS)
- BEHAVIORAL Wellness for MS (WellMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2021-11-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04496804
The ClinicalTrials.gov registry entry for NCT04496804 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Behavioral Intervention for Physical Activity in MS (BIPAMS) is the first listed.
NCT04496804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04496804 about?
NCT04496804 is a clinical study titled "Examining the Neural Effects of a Behavioral Intervention for Physical Activity in Multiple Sclerosis". Multiple sclerosis \[MS\] is a prevalent neurological disease that is the leading cause of irreversible neurological disability among young women and the second leading cause of disability among young men in the United States. This disease results in the progressive loss of walking mobility and subs...
What is the current status of trial NCT04496804?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2020-11-02. Estimated completion is 2021-11-03.
What interventions are being tested in trial NCT04496804?
The interventions under investigation include: Behavioral Intervention for Physical Activity in MS (BIPAMS) (BEHAVIORAL), Wellness for MS (WellMS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04496804?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.